Bluejay Diagnostics (BJDX) Director Fred Zeidman Buys 12,500 Shares

What Happened Fred S. Zeidman, a director of Bluejay Diagnostics, purchased 12,500 shares of the company's common stock in a private placement on March 14, 2026. The shares were acquired at $2.00 per share for a total purchase amount of $25,000. This was a direct purchase from the issuer (transaction code P), which is a buy rather than a sale.

Key Details

• Transaction date: March 14, 2026
• Price: $2.00 per share; Total value: $25,000
• Transaction type: Private placement purchase (issuer sale) — code P
• Shares owned after transaction: Not disclosed in the provided filing
• Footnote: Purchase was from the issuer in a private placement (per filing footnote)
• Filing timeliness: Form 4 filed May 18, 2026 for a March 14 transaction — appears to be filed late (more than the standard 2 business days), which can delay public disclosure

Context Insider purchases are often watched by investors as a sign of confidence, though the relatively small dollar amount here ($25k) limits how strong a signal it may be. A private placement means the company directly sold shares to the director rather than an open-market trade; such transactions can be related to financing or other corporate needs and do not by themselves indicate future performance.